No not at all, but it's my understanding that they need to comply with the timelines set down by the FDA.
To do this they need to be sure of funding.
Ann: Paradigm receives clarity on US regulatory pathway, page-21
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $39.95K | 199.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 192539 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 164484 | 6 |
View Market Depth
| Last trade - 11.29am 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |